Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human)

NDC 68982-182 · Octapharma USA Inc

Generic namevon Willebrand Factor/Coagulation Factor VIII Complex (Human)

Dosage formPOWDER, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)ANTIHEMOPHILIC FACTOR HUMAN, VON WILLEBRAND FACTOR HUMAN

Strength100; 100 [iU]/mL; [iU]/mL

Pharmacologic classBlood Coagulation Factors [CS], Blood Coagulation Factors [CS], Factor VIII [CS], Human Antihemophilic Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Increased Platelet Aggregation [PE], von Willebrand Factor [CS]

Marketing categoryBLA

Packages

68982-182-01 — 5 mL in 1 VIAL (68982-182-01)

68982-182-02 — 10 mL in 1 VIAL (68982-182-02)

Billed under HCPCS

J7183 — Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco Medicare Part B payment limit (ASP + 6%): $1.33

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels